Different Phases of Clinical Trials and What They Mean

Carefully monitored tests to gauge the strengths and side effects of a new medical treatment are crucial to improving care. Learn about each stage in the process.

7:00 AM

Author | Kevin Joy


Before any new drug or treatment can be marketed to the masses, it must be tested to ensure safety and effectiveness.

The process is known as a clinical trial.

MORE FROM MICHIGAN: Sign up for our weekly newsletter

These research studies, which only use volunteer participants, compare potential medications or procedures against current methods — or placebos if an existing treatment isn't available. Clinical trials follow strict procedure to achieve their goals and ensure that everyone involved is safely monitored throughout.

"Clinical trials are important and necessary to help further the therapies that we have available for many different diseases," says Vallerie McLaughlin, M.D., director of the Pulmonary Hypertension Program at the University of Michigan Frankel Cardiovascular Center.

"The only way to get a drug, device, or another intervention approved is to do a clinical trial to demonstrate that the therapy works."

Many trials are underway at the U-M; some involve healthy people while others target those with advanced disease. Costs of the clinical trial and the experimental therapy are generally covered by the trial's sponsor — and patients can withdraw at any time.

Each trial falls within a certain phase. McLaughlin explained the phases and what all participants should know:

What each type of clinical trial means

Phase I: A new medication or treatment is tested for the first time "usually a trial in healthy volunteers to get some information about the dosing of a drug and about the side effects that might be expected," McLaughlin says. Often everyone involved, including participants, knows what medication is being tested a model known as a nonrandomized, nonblinded study.

SEE ALSO: How Clinical Trials Helped Three Cancer Patients Thrive

Phase II: Testing uses a larger group of patients, all with a specific condition or disease. The intent: "to get information about how effective the drug is to treat certain parameters of that disease," McLaughlin says. That helps researchers determine how well a medication or treatment works in response. It's an important step to gather information for the next phase of the development process.

Phase III: Also called a pivotal trial, this phase marks the formation of two groups: those on the new drug and those receiving a standard treatment or placebo. A larger number of participants is often involved. Neither the subjects, doctors or researchers know which option a patient gets. Drugs that reach this stage are typically on a path to FDA approval, McLaughlin notes.

Phase IV: Taking place after federal approval, this phase is meant to find "other indications or scenarios for the drug," McLaughlin says. That could include new uses for a medication, different ways to administer it or additional safety precautions. It's also a chance to study the drug on specific populations, such as the elderly and those with certain racial and ethnic backgrounds.

Video courtesy of phaware global association


More Articles About: Health Management Basic Science and Laboratory Research Health Care Delivery, Policy, and Economics Health Care Quality All Research Topics
Health Lab word mark overlaying blue cells
Health Lab

This article is from the Health Lab digital publication.

Media Contact Public Relations

Department of Communication at Michigan Medicine

MichMedmedia@med.umich.edu

734-764-2220

Newsletter

Get a weekly digest of medical research and innovation, straight to your inbox.

Subscribe
Featured News & Stories Courtney Weirauch and family
Health Lab
A rare diagnosis and a young mother who’s spreading the word
Courtney Weirauch didn’t know what lymphangioleiomyomatosis was – but she quickly learned about the rare lung condition and how it would impact her life.
microscope cells glioma
Health Lab
Researchers circumvent radiation resistance in subtype of brain tumors
University of Michigan Rogel Cancer Center researchers find ZMYND8 gene plays a critical role in conferring radiation resistance on brain tumors with IDH1 mutation.
pediatrician talking with mother at exam questions
Health Lab
Checklist for the checkup: Some parents may not be making the most of well child visits
While many parents keep recommended well visits with their child’s primary provider, some may consider more proactive steps to make checkups as productive as possible
colorful pills falling in a line
Health Lab
For COVID-19, do supplements help?
An expert cautions about becoming too enamored with pills.
Microscope
Health Lab
Studying a protein modification process in worms provides potential insights for human health
Too much of this post-translational modification impacted multiple body systems
scientist examining a kidney
Health Lab
An AI model predicting acute kidney injury works, but not without some tweaking
The model identified AKI 48 hours in advance, allowing ample time for clinicians to intervene and provide treatment.